View Financial HealthSofina Société Anonyme 배당 및 자사주 매입배당 기준 점검 2/6Sofina Société Anonyme 은(는) 현재 수익률이 1.67% 인 배당금 지급 회사입니다. 다음 지급일은 29th May, 2026 이며 배당락일은 다음과 같습니다. 27th May, 2026.핵심 정보1.7%배당 수익률-6.8%자사주 매입 수익률총 주주 수익률-5.1%미래 배당 수익률1.9%배당 성장률4.0%다음 배당 지급일29 May 26배당락일27 May 26주당 배당금n/a배당 성향109%최근 배당 및 자사주 매입 업데이트Declared Dividend • May 22Dividend of €2.56 announcedShareholders will receive a dividend of €2.56. Ex-date: 27th May 2026 Payment date: 29th May 2026 Dividend yield will be 1.1%, which is lower than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (109% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.1% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 21% to bring the payout ratio under control. However, EPS has declined by 40% over the last 5 years so the company would need to reverse this trend.공시 • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.Upcoming Dividend • May 13Upcoming dividend of €2.45 per shareEligible shareholders must have bought the stock before 20 May 2025. Payment date: 22 May 2025. Payout ratio is a comfortable 8.6% but the company is paying out more than the cash it is generating. Trailing yield: 1.4%. Lower than top quartile of Belgian dividend payers (6.7%). Lower than average of industry peers (2.8%).Upcoming Dividend • May 05Upcoming dividend of €2.27 per share at 1.6% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Belgian dividend payers (6.4%). Lower than average of industry peers (2.6%).Upcoming Dividend • May 06Upcoming dividend of €2.19 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Payout ratio is a comfortable 4.1% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Belgian dividend payers (5.7%). Lower than average of industry peers (2.6%).모든 업데이트 보기Recent updatesDeclared Dividend • May 22Dividend of €2.56 announcedShareholders will receive a dividend of €2.56. Ex-date: 27th May 2026 Payment date: 29th May 2026 Dividend yield will be 1.1%, which is lower than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (109% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.1% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 21% to bring the payout ratio under control. However, EPS has declined by 40% over the last 5 years so the company would need to reverse this trend.공시 • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.공시 • Apr 11Sofina Société Anonyme, Annual General Meeting, May 13, 2026Sofina Société Anonyme, Annual General Meeting, May 13, 2026, at 15:00 Romance Standard Time.New Risk • Mar 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 58% Last year net profit margin: 95% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (58% net profit margin).공시 • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 25% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).새로운 내러티브 • Feb 04Why I invest in Sofina (Dividend growth)NAV As Sofina is an investment holding company, NAV is an important factor in my evaluation. This Net Asset Value is estimated at a price share of 297 Eur, up from 294 last year.분석 기사 • Jan 02Getting In Cheap On Sofina Société Anonyme (EBR:SOF) Is UnlikelyWhen close to half the companies in Belgium have price-to-earnings ratios (or "P/E's") below 15x, you may consider...공시 • Oct 30Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire remaining 99.5% stake in OrganOx Limited from a group of shareholders for $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. The transaction will be funded from cash on hand and borrowings. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. The transaction is expected to close in FY2025. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Robbie McLaren, Ross McAloon, Charles Ruck, Elizabeth Richards, Betty Pang, Chad Jennings, Sean Finn, Maj Vaseghi, Kendall Burnett, Hector Armengod, Patrick English, Catherine Hein and Philipp Studt of Latham & Watkins acted as legal counsel to OrganOx in this transaction. Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders on October 29, 2025.분석 기사 • Sep 07Some Shareholders Feeling Restless Over Sofina Société Anonyme's (EBR:SOF) P/E RatioSofina Société Anonyme's ( EBR:SOF ) price-to-earnings (or "P/E") ratio of 20.2x might make it look like a sell right...공시 • Sep 04Sofina Société Anonyme to Report First Half, 2026 Results on Sep 03, 2026Sofina Société Anonyme announced that they will report first half, 2026 results on Sep 03, 2026공시 • Aug 25Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Latham & Watkins acted as legal counsel to OrganOx in this transaction.Upcoming Dividend • May 13Upcoming dividend of €2.45 per shareEligible shareholders must have bought the stock before 20 May 2025. Payment date: 22 May 2025. Payout ratio is a comfortable 8.6% but the company is paying out more than the cash it is generating. Trailing yield: 1.4%. Lower than top quartile of Belgian dividend payers (6.7%). Lower than average of industry peers (2.8%).공시 • Apr 25Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million.Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million on April 24, 2025. A cash consideration valued at €34.01 per share will be paid by Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme. As part of consideration, an undisclosed value is paid towards common equity of Proeduca Altus, S.A. The proposed price for the offer is €34.01 per share, valuing the Proeduca Altus at approximately €1.536 billion. The transaction is subject to Proeduca Altus shareholders approval. Ernst & Young Transaction Advisory Services España acted as fairness opinion provider to Proeduca Altus, S.A.공시 • Mar 27Sofina Société Anonyme to Report Fiscal Year 2025 Final Results on Mar 26, 2026Sofina Société Anonyme announced that they will report fiscal year 2025 final results on Mar 26, 2026New Risk • Mar 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).Price Target Changed • Jul 11Price target decreased by 14% to €292Down from €341, the current price target is an average from 3 analysts. New target price is 36% above last closing price of €214. Stock is up 9.3% over the past year. The company posted a net loss per share of €3.12 last year.공시 • Apr 04Sofina Société Anonyme, Annual General Meeting, May 08, 2025Sofina Société Anonyme, Annual General Meeting, May 08, 2025.공시 • Mar 29Sofina Société Anonyme to Report Fiscal Year 2024 Results on Mar 26, 2025Sofina Société Anonyme announced that they will report fiscal year 2024 results on Mar 26, 2025New Risk • Mar 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 22% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).공시 • Jan 23Sofina Société Anonyme to Report First Half, 2024 Results on Sep 05, 2024Sofina Société Anonyme announced that they will report first half, 2024 results on Sep 05, 2024공시 • Dec 20Proofpoint, Inc. acquire Tessian Limited.Proofpoint, Inc. entered into a definitive agreement to acquire Tessian Limited on October 30, 2023. Tessian’s solutions are expected to become part of Proofpoint’s offering upon the closing of the acquisition. The acquisition is expected to close in late 2023 to early 2024, subject to customary closing conditions, including any required regulatory approvals. Piper Sandler Ltd. acted as financial advisor to Tessian Limited. Vincent Bergin, Peter Stach, P.C., Andrew Struckmeyer, David Higgins, Corey D. Fox, P.C., Bradley C. Reed, P.C., John Patten, Peter Abbott, Matthew Sinclair-Thomson, Kirsteen Nicol, Katherine C. Nemeth, Michael Falk, P.C., Sydney Jones and Jackson Phinney of Kirkland & Ellis International LLP and Kirkland & Ellis LLP acted as legal advisor to Proofpoint. The transaction is closed on December 19, 2023.Proofpoint, Inc. completed the acquisition of Tessian Limited on December 19, 2023.Upcoming Dividend • May 05Upcoming dividend of €2.27 per share at 1.6% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Belgian dividend payers (6.4%). Lower than average of industry peers (2.6%).Price Target Changed • Nov 16Price target decreased to €367Down from €415, the current price target is an average from 2 analysts. New target price is 66% above last closing price of €221. Stock is down 45% over the past year. The company posted earnings per share of €76.99 last year.Price Target Changed • Jun 01Price target decreased to €367Down from €420, the current price target is provided by 1 analyst. New target price is 69% above last closing price of €217. Stock is down 37% over the past year. The company posted earnings per share of €76.99 last year.Valuation Update With 7 Day Price Move • May 24Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €234, the stock trades at a trailing P/E ratio of 3x. Average trailing P/E is 9x in the Diversified Financial industry in Europe. Total returns to shareholders of 35% over the past three years.Upcoming Dividend • May 06Upcoming dividend of €2.19 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Payout ratio is a comfortable 4.1% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Belgian dividend payers (5.7%). Lower than average of industry peers (2.6%).Price Target Changed • Jul 24Price target increased to €348Up from €310, the current price target is provided by 1 analyst. New target price is 12% below last closing price of €396. Stock is up 70% over the past year.Price Target Changed • Mar 22Price target increased to €310Up from €283, the current price target is provided by 1 analyst. New target price is 6.7% above last closing price of €291. Stock is up 74% over the past year.Is New 90 Day High Low • Feb 03New 90-day high: €286The company is up 22% from its price of €235 on 04 November 2020. The Belgian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 17% over the same period.Is New 90 Day High Low • Dec 29New 90-day high: €275The company is up 18% from its price of €233 on 30 September 2020. The Belgian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 12% over the same period.Is New 90 Day High Low • Nov 17New 90-day high: €260The company is up 7.0% from its price of €243 on 19 August 2020. The Belgian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Diversified Financial industry, which is up 5.0% over the same period.Is New 90 Day High Low • Oct 29New 90-day low: €223The company is down 4.0% from its price of €234 on 30 July 2020. The Belgian market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is down 6.0% over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: SOF 의 주당 배당금은 지난 10 년 동안 안정적이었습니다.배당금 증가: SOF 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장Sofina Société Anonyme 배당 수익률 vs 시장SOF의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (SOF)1.7%시장 하위 25% (BE)2.4%시장 상위 25% (BE)6.5%업계 평균 (Diversified Financial)4.3%분석가 예측 (SOF) (최대 3년)1.9%주목할만한 배당금: SOF 의 배당금( 1.67% )은 Belgian 시장에서 배당금 지급자의 하위 25%( 2.4% )와 비교해 주목할 만하지 않습니다.고배당: SOF 의 배당금( 1.67% )은 Belgian 시장에서 배당금 지급자의 상위 25%( 6.53% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 지급 비율 ( 109.3% )이 높기 때문에 SOF 의 배당금 지급은 수익으로 잘 충당되지 않습니다.주주 현금 배당현금 흐름 범위: SOF 배당금을 지급하고 있지만 회사에는 잉여현금흐름이 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YBE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/27 05:18종가2026/05/27 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Sofina Société Anonyme는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Marc DebrouwerDegroof Petercam
Declared Dividend • May 22Dividend of €2.56 announcedShareholders will receive a dividend of €2.56. Ex-date: 27th May 2026 Payment date: 29th May 2026 Dividend yield will be 1.1%, which is lower than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (109% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.1% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 21% to bring the payout ratio under control. However, EPS has declined by 40% over the last 5 years so the company would need to reverse this trend.
공시 • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.
Upcoming Dividend • May 13Upcoming dividend of €2.45 per shareEligible shareholders must have bought the stock before 20 May 2025. Payment date: 22 May 2025. Payout ratio is a comfortable 8.6% but the company is paying out more than the cash it is generating. Trailing yield: 1.4%. Lower than top quartile of Belgian dividend payers (6.7%). Lower than average of industry peers (2.8%).
Upcoming Dividend • May 05Upcoming dividend of €2.27 per share at 1.6% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Belgian dividend payers (6.4%). Lower than average of industry peers (2.6%).
Upcoming Dividend • May 06Upcoming dividend of €2.19 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Payout ratio is a comfortable 4.1% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Belgian dividend payers (5.7%). Lower than average of industry peers (2.6%).
Declared Dividend • May 22Dividend of €2.56 announcedShareholders will receive a dividend of €2.56. Ex-date: 27th May 2026 Payment date: 29th May 2026 Dividend yield will be 1.1%, which is lower than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (109% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.1% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 21% to bring the payout ratio under control. However, EPS has declined by 40% over the last 5 years so the company would need to reverse this trend.
공시 • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.
공시 • Apr 11Sofina Société Anonyme, Annual General Meeting, May 13, 2026Sofina Société Anonyme, Annual General Meeting, May 13, 2026, at 15:00 Romance Standard Time.
New Risk • Mar 29New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 58% Last year net profit margin: 95% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (58% net profit margin).
공시 • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027
New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 25% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
새로운 내러티브 • Feb 04Why I invest in Sofina (Dividend growth)NAV As Sofina is an investment holding company, NAV is an important factor in my evaluation. This Net Asset Value is estimated at a price share of 297 Eur, up from 294 last year.
분석 기사 • Jan 02Getting In Cheap On Sofina Société Anonyme (EBR:SOF) Is UnlikelyWhen close to half the companies in Belgium have price-to-earnings ratios (or "P/E's") below 15x, you may consider...
공시 • Oct 30Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire remaining 99.5% stake in OrganOx Limited from a group of shareholders for $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. The transaction will be funded from cash on hand and borrowings. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. The transaction is expected to close in FY2025. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Robbie McLaren, Ross McAloon, Charles Ruck, Elizabeth Richards, Betty Pang, Chad Jennings, Sean Finn, Maj Vaseghi, Kendall Burnett, Hector Armengod, Patrick English, Catherine Hein and Philipp Studt of Latham & Watkins acted as legal counsel to OrganOx in this transaction. Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders on October 29, 2025.
분석 기사 • Sep 07Some Shareholders Feeling Restless Over Sofina Société Anonyme's (EBR:SOF) P/E RatioSofina Société Anonyme's ( EBR:SOF ) price-to-earnings (or "P/E") ratio of 20.2x might make it look like a sell right...
공시 • Sep 04Sofina Société Anonyme to Report First Half, 2026 Results on Sep 03, 2026Sofina Société Anonyme announced that they will report first half, 2026 results on Sep 03, 2026
공시 • Aug 25Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Latham & Watkins acted as legal counsel to OrganOx in this transaction.
Upcoming Dividend • May 13Upcoming dividend of €2.45 per shareEligible shareholders must have bought the stock before 20 May 2025. Payment date: 22 May 2025. Payout ratio is a comfortable 8.6% but the company is paying out more than the cash it is generating. Trailing yield: 1.4%. Lower than top quartile of Belgian dividend payers (6.7%). Lower than average of industry peers (2.8%).
공시 • Apr 25Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million.Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million on April 24, 2025. A cash consideration valued at €34.01 per share will be paid by Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme. As part of consideration, an undisclosed value is paid towards common equity of Proeduca Altus, S.A. The proposed price for the offer is €34.01 per share, valuing the Proeduca Altus at approximately €1.536 billion. The transaction is subject to Proeduca Altus shareholders approval. Ernst & Young Transaction Advisory Services España acted as fairness opinion provider to Proeduca Altus, S.A.
공시 • Mar 27Sofina Société Anonyme to Report Fiscal Year 2025 Final Results on Mar 26, 2026Sofina Société Anonyme announced that they will report fiscal year 2025 final results on Mar 26, 2026
New Risk • Mar 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).
Price Target Changed • Jul 11Price target decreased by 14% to €292Down from €341, the current price target is an average from 3 analysts. New target price is 36% above last closing price of €214. Stock is up 9.3% over the past year. The company posted a net loss per share of €3.12 last year.
공시 • Apr 04Sofina Société Anonyme, Annual General Meeting, May 08, 2025Sofina Société Anonyme, Annual General Meeting, May 08, 2025.
공시 • Mar 29Sofina Société Anonyme to Report Fiscal Year 2024 Results on Mar 26, 2025Sofina Société Anonyme announced that they will report fiscal year 2024 results on Mar 26, 2025
New Risk • Mar 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 22% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).
공시 • Jan 23Sofina Société Anonyme to Report First Half, 2024 Results on Sep 05, 2024Sofina Société Anonyme announced that they will report first half, 2024 results on Sep 05, 2024
공시 • Dec 20Proofpoint, Inc. acquire Tessian Limited.Proofpoint, Inc. entered into a definitive agreement to acquire Tessian Limited on October 30, 2023. Tessian’s solutions are expected to become part of Proofpoint’s offering upon the closing of the acquisition. The acquisition is expected to close in late 2023 to early 2024, subject to customary closing conditions, including any required regulatory approvals. Piper Sandler Ltd. acted as financial advisor to Tessian Limited. Vincent Bergin, Peter Stach, P.C., Andrew Struckmeyer, David Higgins, Corey D. Fox, P.C., Bradley C. Reed, P.C., John Patten, Peter Abbott, Matthew Sinclair-Thomson, Kirsteen Nicol, Katherine C. Nemeth, Michael Falk, P.C., Sydney Jones and Jackson Phinney of Kirkland & Ellis International LLP and Kirkland & Ellis LLP acted as legal advisor to Proofpoint. The transaction is closed on December 19, 2023.Proofpoint, Inc. completed the acquisition of Tessian Limited on December 19, 2023.
Upcoming Dividend • May 05Upcoming dividend of €2.27 per share at 1.6% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Belgian dividend payers (6.4%). Lower than average of industry peers (2.6%).
Price Target Changed • Nov 16Price target decreased to €367Down from €415, the current price target is an average from 2 analysts. New target price is 66% above last closing price of €221. Stock is down 45% over the past year. The company posted earnings per share of €76.99 last year.
Price Target Changed • Jun 01Price target decreased to €367Down from €420, the current price target is provided by 1 analyst. New target price is 69% above last closing price of €217. Stock is down 37% over the past year. The company posted earnings per share of €76.99 last year.
Valuation Update With 7 Day Price Move • May 24Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to €234, the stock trades at a trailing P/E ratio of 3x. Average trailing P/E is 9x in the Diversified Financial industry in Europe. Total returns to shareholders of 35% over the past three years.
Upcoming Dividend • May 06Upcoming dividend of €2.19 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Payout ratio is a comfortable 4.1% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Belgian dividend payers (5.7%). Lower than average of industry peers (2.6%).
Price Target Changed • Jul 24Price target increased to €348Up from €310, the current price target is provided by 1 analyst. New target price is 12% below last closing price of €396. Stock is up 70% over the past year.
Price Target Changed • Mar 22Price target increased to €310Up from €283, the current price target is provided by 1 analyst. New target price is 6.7% above last closing price of €291. Stock is up 74% over the past year.
Is New 90 Day High Low • Feb 03New 90-day high: €286The company is up 22% from its price of €235 on 04 November 2020. The Belgian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 17% over the same period.
Is New 90 Day High Low • Dec 29New 90-day high: €275The company is up 18% from its price of €233 on 30 September 2020. The Belgian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is up 12% over the same period.
Is New 90 Day High Low • Nov 17New 90-day high: €260The company is up 7.0% from its price of €243 on 19 August 2020. The Belgian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Diversified Financial industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Oct 29New 90-day low: €223The company is down 4.0% from its price of €234 on 30 July 2020. The Belgian market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Diversified Financial industry, which is down 6.0% over the same period.
